Weight Watchers Med+
What we're doing
Our mission is to make healthcare more accessible, more transparent, and friendlier. Weight Watchers Med+ addresses chronic obesity, which affects over 50% of adults and is tightly correlated to many other chronic conditions.
We're taking the following steps to accomplish this:
-
Building a best in class technology platform to connect patients with board-certified obesity specialists who can provide the highest quality of care
-
Prescribing revolutionary GLP-1 medications like Wegovy, Ozempic, and Mounjaro
-
Assembling a team of highly motivated Clinicians, Registered Dietitians, and Fitness Coaches to deliver results for our members in their journeys toward better health
Weekend Health was acquired by Weight Watchers (NASDAQ: WW) in 2023, and works closely with the WW team as a subsidiary. We'll be continuing on a path of rapid growth together, combining WW's world class behavioral health programs with Weekend Health's clinical expertise in obesity treatment.
We believe that healthcare shouldn't feel like work — it should feel fun, friendly, and personal.